T/ZNX 012-2021
40% Cyazofamida Dimethomorph Suspension Concentrate (English Version)
- Standard No.
- T/ZNX 012-2021
- Language
- Chinese, Available in English version
- Release Date
- 2021
- Published By
- Group Standards of the People's Republic of China
- Latest
- T/ZNX 012-2021
- Scope
- Project indicators: cyanomorphazole mass fraction/% 9.0~11.0 dimethomorph mass fraction/% 28.5~31.5 pH value 5.0~8.0 cyanomorphazole suspension rate/% ≥90 dimethomorph suspension rate/% ≥90 Pourability, Residue after pouring/% ≤5.0 Pourability, residue after washing/% ≤0.5 Wet sieve test (passes 75μm test sieve)/% ≥98 Long-lasting foaming property (foam amount after 1 min)/mL≤40 Low temperature stability test a After cold storage, the suspension rate and wet sieving test still meet the requirements of this document. Thermal storage stability test a After thermal storage, the mass fraction of cyanomorphazole (or dimethomorph) should not be lower than 95% of that before storage, and the pH value, suspension rate, pourability, and wet sieving test still meet the requirements of this document. a During normal production, low-temperature stability and thermal storage stability tests should be measured at least once every three months.
T/ZNX 012-2021 history
- 2021 T/ZNX 012-2021 40% Cyazofamida Dimethomorph Suspension Concentrate
